Study Evaluating ASTRA TECH Implant System, OsseoSpeed™ Implants in the Upper Jaw in Women With Osteoporosis

Exclusion Criteria

• •Unlikely to be able to comply with study procedures, as judged by the investigator.
• •Untreated, uncontrolled caries and/or periodontal disease
• •Known or suspected current malignancy
• •History of chemotherapy within 5 years prior to surgery
• •History of radiation in the head and neck region
• •History of other metabolic bone diseases, e.g. Paget's disease, hyperparathyroidism, fibrous dysplasia or osteomalacia
• •A medical history that makes implant insertion unfavourable
• •Need for systemic corticosteroids
• •Current or previous use of intravenous bisphosphonates (esp. zoledronic acid)
• •Current or previous use of oral bisphosphonates
• •History of bone grafting and/or sinus lift in the planned implant area
• •Current need for bone grafting and/or sinus lift in the planned implant area
• •Present alcohol and/or drug abuse
• •Involvement in the planning and conduct of the study (applies to both Astra Tech AB staff or staff at the study site)
• •Previous enrolment in the present study.
• •Participation in a clinical study during the last 6 months.